Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Microbiota of the Stomach and Small Intestine

Microbiota of the Stomach and Small Intestine

The human gastrointestinal (GI) tract is characterized by distinct physicochemical conditions that shape its microbial communities. Among these, the stomach presents a particularly challenging environment for microbial colonization due to its highly acidic pH, ranging from 1 to 3. This extreme acidity effectively limits microbial density. However, certain acid-tolerant microorganisms are capable of surviving in this niche. Notably, Helicobacter pylori can colonize the gastric mucosa,...

Microbiota of the Large Intestine

Microbiota of the Large Intestine

The large intestine hosts the most densely populated microbial ecosystem in the human body. This complex community primarily consists of anaerobic bacteria, with Bacillota (formerly Firmicutes) and Bacteroidota (formerly Bacteroidetes) as the predominant groups. The distribution of these microbes varies along different sections of the large intestine, influenced by local environmental factors such as oxygen availability and nutrient composition.The cecum, located at the beginning of the large...

Functions of the Gut Microbiota

Functions of the Gut Microbiota

The gut microbiota includes trillions of microorganisms that colonize the human gastrointestinal tract, including bacteria, archaea, viruses, and fungi. This complex ecosystem plays a critical role in maintaining intestinal and systemic health. Most of these microbes inhabit the large intestine, establishing a relatively stable and diverse community that contributes to gut homeostasis through various metabolic, immunological, and protective mechanisms.Dominant bacterial phyla, such as...

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...

Inflammatory Bowel Disease I: Ulcerative Colitis

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

Inflammatory Bowel Disease III: Crohn's Disease

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Dietary Protein Source Mediates Colitis Pathogenesis Through Bacterial Modulation of Bile Acids.

Cellular and molecular gastroenterology and hepatology·2026

Same author

Activity-guided substructure prioritization accelerates discovery of gut microbiota-derived immune-regulating metabolites.

Nature communications·2026

Same author

Dysbiotic microbiota trigger colitis-associated colorectal cancer and imprint a distinctive bile acid profile in a PSC-IBD model.

Gut·2026

Same author

Reduced Intestinal GLP-1<sup>+</sup> Cell Numbers Are Associated With an Inflammation-related Epithelial Metabolic Signature.

Cellular and molecular gastroenterology and hepatology·2025

Same author

Reduced intestinal GLP-1 <sup>+</sup> cell numbers are associated with an inflammation-related epithelial metabolic signature.

bioRxiv : the preprint server for biology·2025

Same author

Presentation of the AGA Distinguished Achievement Award in Basic Science to Eugene B. Chang, MD, AGAF.

Gastroenterology·2025

Search research articles

Related Experiment Video

Updated: May 15, 2026

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach

Published on: May 2, 2018

Enteric Microflora in IBD: Pathogens or Commensals?

R Balfour Sartor¹

¹Department of Medicine, University of North Carolina, Division of Digestive Diseases, Chapel Hill, North Carolina, U.S.A.

Inflammatory Bowel Diseases

|January 4, 2013

Summary

This summary is machine-generated.

Both harmful and normal gut bacteria can trigger chronic intestinal inflammation in susceptible individuals. Modifying gut bacteria may offer new treatments for inflammatory bowel diseases (IBD).

More Related Videos

Chronic Salmonella Infection Induced Intestinal Fibrosis

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

Related Experiment Videos

Last Updated: May 15, 2026

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach

Published on: May 2, 2018

Chronic Salmonella Infection Induced Intestinal Fibrosis

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

Area of Science:

Gastroenterology
Immunology
Microbiology

Background:

Enteric microflora plays a role in chronic intestinal inflammation.
Genetic susceptibility is a key factor in developing inflammatory bowel diseases (IBD).
The role of specific pathogens in IBD etiology is still under investigation.

Purpose of the Study:

To investigate the role of enteric microflora in initiating and perpetuating chronic intestinal inflammation.
To explore the potential of altering gut bacteria for therapeutic interventions in IBD.

Main Methods:

Review of current research on the interaction between host genetics, enteric microflora, and intestinal inflammation.
Analysis of findings from animal models (germ-free environments) to understand the impact of resident bacteria.

Main Results:

Both pathogenic and commensal bacteria can induce inflammation in genetically susceptible hosts.
Absence of inflammation in germ-free animal models highlights the importance of resident bacteria.
Different bacterial species exhibit varying capacities to induce mucosal injury, with some being protective.

Conclusions:

Enteric microflora, both pathogenic and normal, can induce and perpetuate chronic intestinal inflammation.
While specific pathogens are not definitively proven causes, transient infections may act as triggers.
Altering luminal bacterial composition presents a potential therapeutic strategy for IBD.